NUVA — NuVasive Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid Cap

Annual balance sheet for NuVasive, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	118	213	1,030	246	249
Net Total Accounts Receivable
Net Total Receivables	196	212	207	214	249
Total Inventory
Prepaid Expenses
Total Current Assets	618	764	1,562	802	865
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	239	333	389	407	442
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1,708	1,885	2,693	2,154	2,225
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	179	207	836	201	716
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	873	970	1,774	1,359	1,356
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	835	915	919	795	869
Total Liabilities & Shareholders' Equity	1,708	1,885	2,693	2,154	2,225
Total Common Shares Outstanding